欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0945/002
药品名称
Aripiprazol Mylan Italia
活性成分
aripiprazole 15.0 mg
剂型
Orodispersible tablet
上市许可持有人
Mylan S.p.A. Via Vittor Pisani 20 20124 Milan Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Portugal (PT)
许可日期
2015/03/25
最近更新日期
2024/05/10
药物ATC编码
N05AX12 aripiprazole
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
immediate_packaging_oral_sol
Date of last change:2024/09/06
Final Product Information
|
immediate_packaging_oro
Date of last change:2024/09/06
Final Product Information
|
immediate_packaging_tab
Date of last change:2024/09/06
Final Product Information
|
outer_packaging_oral_sol
Date of last change:2024/09/06
Final Product Information
|
outer_packaging_oro
Date of last change:2024/09/06
Final Product Information
|
outer_packaging_tab
Date of last change:2024/09/06
Final Product Information
|
pl_oral_sol
Date of last change:2024/09/06
Final Product Information
|
pl_oro_tab
Date of last change:2024/09/06
Final Product Information
|
pl_tab
Date of last change:2024/09/06
Final Product Information
|
SmPC_oral_soL
Date of last change:2024/09/06
Final Product Information
|
SmPC_oro_tab
Date of last change:2024/09/06
Final Product Information
|
SmPC_tab
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase